secwatch.observer — SEC 8-K summary
======================================

Issuer:     Orgenesis Inc. (—)
CIK:        0001460602
Form:       8-K
Filed at:   2024-03-01T23:59:59+00:00
Accession:  0001493152-24-008483
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.85
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Orgenesis Signs $8.34M Binding Term Sheet for OMPUL Sale and Leaseback with Germfree
--------------------------------------------------------------------------------

- Germfree to purchase five OMPULs for $6.84M and lease them back to Orgenesis Maryland.
- Germfree paid $750K upfront; refundable if definitive agreements not signed within 21 days.
- Orgenesis grants exclusive royalty-free license for Quality Management System; $250K due at signing.
- Parties to negotiate 10-year exclusive Manufacturing Supply Agreement; additional $250K at signing.
- Germfree commits $3.3M in working capital to produce OMPULs as part of the strategic collaboration.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1460602/000149315224008483/0001493152-24-008483-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1460602/000149315224008483/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-008483

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer